Overview
Xuhong Liao practices practicing medicine in Beijing, China.
Their clinical expertise encompasses Alzheimer's Disease, Dementia, Autism Spectrum Disorder, and Major Depression.
They are actively involved in clinical research, co-authoring 48 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Xuhong Liao
Is Xuhong Liao a top-rated expert for Alzheimer's Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Xuhong Liao is classified as an Experienced expert for Alzheimer's Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Xuhong Liao participate in research or clinical trials?
Yes. Xuhong Liao has published 48 articles and abstracts on conditions like Alzheimer's Disease. You can view a list of Xuhong Liao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Alzheimer's DiseaseLiao isExperienced. Learn about Alzheimer's Disease.
- Autism Spectrum DisorderLiao isExperienced. Learn about Autism Spectrum Disorder.
- DementiaLiao isExperienced. Learn about Dementia.
- Major DepressionLiao isExperienced. Learn about Major Depression.